News & Updates

Nivolumab plus chemo offers prolonged survival in resectable NSCLC
Nivolumab plus chemo offers prolonged survival in resectable NSCLC
14 Jun 2024 byStephen Padilla

Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate 816 study.

Nivolumab plus chemo offers prolonged survival in resectable NSCLC
14 Jun 2024
COVID-19 does mess with the brain even years after infection
COVID-19 does mess with the brain even years after infection
06 Jun 2024 byAudrey Abella

A long-term study showed that individuals who have recovered from COVID-19 continued to experience cognitive, psychiatric, and neurological issues, as well as brain functional alteration, even 2 years after being infected.

COVID-19 does mess with the brain even years after infection
06 Jun 2024
FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
05 Jun 2024 byStephen Padilla

Patients with postacute COVID-19 syndrome (PACS) may benefit from faecal microbiota transplantation (FMT) treatment, which helps reduce anxiety and improve sleep quality, suggests a study.

FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
05 Jun 2024